DC Field
Value
Language
dc.contributor.author
Hecko, Sebastian
-
dc.contributor.author
Vleugels, Marle
-
dc.contributor.author
Bayer, Christian
-
dc.contributor.author
Byun, Donghak
-
dc.contributor.author
Moa E. Hörberg
-
dc.contributor.author
Poremba, Nikolaus
-
dc.contributor.author
Boukraa, Rassen
-
dc.contributor.author
Keppel, Patrick
-
dc.contributor.author
Löffler, Andreas
-
dc.contributor.author
Kuba, W.
-
dc.contributor.author
Saarela Unemo, Helena
-
dc.contributor.author
Bernacka-Wojcik, Iwona
-
dc.contributor.author
Arbring Sjöström, Theresia
-
dc.contributor.author
Berggren, Magnus
-
dc.contributor.author
Simon, Daniel
-
dc.contributor.author
Schindl, Rainer
-
dc.contributor.author
Waldherr, Linda
-
dc.contributor.author
Mikula, Hannes
-
dc.contributor.author
Bintinger, Johannes
-
dc.date.accessioned
2026-01-14T16:48:32Z
-
dc.date.available
2026-01-14T16:48:32Z
-
dc.date.issued
2025-10-08
-
dc.identifier.citation
<div class="csl-bib-body">
<div class="csl-entry">Hecko, S., Vleugels, M., Bayer, C., Byun, D., Moa E. Hörberg, Poremba, N., Boukraa, R., Keppel, P., Löffler, A., Kuba, W., Saarela Unemo, H., Bernacka-Wojcik, I., Arbring Sjöström, T., Berggren, M., Simon, D., Schindl, R., Waldherr, L., Mikula, H., & Bintinger, J. (2025, October 8). <i>Expanding Iontronic Drug Delivery Via Bioorthogonal Click–to–Release (C2R)</i> [Poster Presentation]. ChemBioParis 2025, France. http://hdl.handle.net/20.500.12708/224416</div>
</div>
-
dc.identifier.uri
http://hdl.handle.net/20.500.12708/224416
-
dc.description.abstract
Iontronic devices or “ion pumps” enable electronically controlled delivery or of molecules through ion–selective membranes with exceptional spatiotemporal resolution. This transport occurs without any fluid movement or mechanical components, making it particularly well suited for precise and reliable therapeutic release. However, this transport mechanism is inherently limited to charged, low molecular weight (<500 g/mol) and electrochemically stable compounds. To overcome these constraints, we present BioSWITCH, a hybrid delivery strategy that decouples molecular transport from therapeutic activation by integrating iontronic delivery with bioorthogonal click–to–release (C2R) chemistry. In this system, charged aminoethyl tetrazines are delivered iontronically to a localized prodrug reservoir, where they undergo an inverse electron demand Diels-Alder (IEDDA) reaction with trans–cyclooctene (cTCO) caged compounds. This enables precise, bioorthogonal activation of therapeutic payloads, irrespective of their molecular size or charge. We demonstrated programmable tetrazine delivery over multiple days using periodic device operation and subsequently validated the concept through activation of potent anti mitotic agent Combretastatin A-4 (CA4). Iontronic tetrazine delivery activated the bound CA4-prodrug, resulting in antiproliferative effects in glioblastoma cell models. Building on these results, we also achieved controlled release of the protein bovine serum albumin (BSA), demonstrating the platform’s ability to overcome the size limitations of conventional iontronic systems. The amount of released protein scaled linearly with the duration of tetrazine delivery, enabling precise, time dependent control over macromolecular release. Together, these results establish BioSWITCH as a novel approach that extends the capabilities of iontronic pumps toward the controlled release of both small molecules and macromolecular therapeutics.
en
dc.description.sponsorship
European Commission
-
dc.description.sponsorship
European Commission
-
dc.description.sponsorship
European Commission
-
dc.language.iso
en
-
dc.subject
Bioorthogonal Chemistry
en
dc.subject
Iontronic Delivery
en
dc.subject
Drug Delivery
en
dc.subject
Electroceuticals
en
dc.title
Expanding Iontronic Drug Delivery Via Bioorthogonal Click–to–Release (C2R)
en
dc.type
Presentation
en
dc.type
Vortrag
de
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Medical University of Graz, Austria
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Linköping University, Sweden
-
dc.contributor.affiliation
Medical University of Graz, Austria
-
dc.contributor.affiliation
Medical University of Graz, Austria
-
dc.relation.grantno
101099963
-
dc.relation.grantno
101117736
-
dc.relation.grantno
101042881
-
dc.type.category
Poster Presentation
-
tuw.project.title
Bioorthogonal Implantable Iontronic Switch to Temporally Control the Local Release of Chemotherapeutics
-
tuw.project.title
Bioorthogonale iontronische Chemie: Wirkstoff-Transport mit elektronischer Präzision
-
tuw.project.title
Bioorthogonal Cascade-Targeting: Directing Drugs into Cells with Molecular Precision
-
tuw.researchinfrastructure
Zentrum für Kernspinresonanzspektroskopie
-
tuw.researchTopic.id
M6
-
tuw.researchTopic.name
Biological and Bioactive Materials
-
tuw.researchTopic.value
100
-
tuw.publication.orgunit
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
tuw.author.orcid
0000-0002-6210-4425
-
tuw.author.orcid
0000-0002-6686-3568
-
tuw.author.orcid
0009-0009-2470-2617
-
tuw.author.orcid
0000-0001-5799-7858
-
tuw.author.orcid
0000-0002-2119-9755
-
tuw.author.orcid
0009-0006-5206-469X
-
tuw.author.orcid
0000-0001-6910-6813
-
tuw.author.orcid
0009-0001-7662-6021
-
tuw.author.orcid
0000-0002-7135-8275
-
tuw.author.orcid
0000-0001-7729-0251
-
tuw.author.orcid
0000-0001-5154-0291
-
tuw.author.orcid
0000-0002-2799-3490
-
tuw.author.orcid
0000-0001-9817-1358
-
tuw.author.orcid
0000-0002-9218-9722
-
tuw.author.orcid
0000-0002-6397-4254
-
tuw.event.name
ChemBioParis 2025
en
dc.description.sponsorshipexternal
Austrian Science Fund (FWF)
-
dc.description.sponsorshipexternal
Austrian Science Fund (FWF)
-
dc.description.sponsorshipexternal
Austrian Science Fund (FWF)
-
dc.relation.grantnoexternal
10.55776/J4304
-
dc.relation.grantnoexternal
10.55776/I4623
-
dc.relation.grantnoexternal
10.55776/Y1443
-
tuw.event.startdate
06-10-2025
-
tuw.event.enddate
09-10-2025
-
tuw.event.online
On Site
-
tuw.event.type
Event for scientific audience
-
tuw.event.country
FR
-
tuw.event.presenter
Hecko, Sebastian
-
tuw.event.track
Single Track
-
wb.sciencebranch
Chemie
-
wb.sciencebranch
Pharmazie, Pharmakologie, Toxikologie
-
wb.sciencebranch
Elektrotechnik, Elektronik, Informationstechnik
-
wb.sciencebranch.oefos
1040
-
wb.sciencebranch.oefos
3012
-
wb.sciencebranch.oefos
2020
-
wb.sciencebranch.value
50
-
wb.sciencebranch.value
25
-
wb.sciencebranch.value
25
-
item.openairetype
conference poster not in proceedings
-
item.openairecristype
http://purl.org/coar/resource_type/c_18co
-
item.cerifentitytype
Publications
-
item.languageiso639-1
en
-
item.grantfulltext
restricted
-
item.fulltext
no Fulltext
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Medical University of Graz, Austria
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Linköping University, Sweden
-
crisitem.author.dept
Medical University of Graz, Austria
-
crisitem.author.dept
Medical University of Graz, Austria
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.dept
E163-03-2 - Forschungsgruppe Molekulare Chemie und Chemische Biologie
-
crisitem.author.orcid
0000-0002-6210-4425
-
crisitem.author.orcid
0000-0002-6686-3568
-
crisitem.author.orcid
0009-0009-2470-2617
-
crisitem.author.orcid
0000-0001-5799-7858
-
crisitem.author.orcid
0009-0006-5206-469X
-
crisitem.author.orcid
0000-0001-6910-6813
-
crisitem.author.orcid
0009-0001-7662-6021
-
crisitem.author.orcid
0000-0002-7135-8275
-
crisitem.author.orcid
0000-0001-7729-0251
-
crisitem.author.orcid
0000-0001-5154-0291
-
crisitem.author.orcid
0000-0002-2799-3490
-
crisitem.author.orcid
0000-0001-9817-1358
-
crisitem.author.orcid
0000-0002-9218-9722
-
crisitem.author.orcid
0000-0002-6397-4254
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.author.parentorg
E163-03 - Forschungsbereich Organische und Biologische Chemie
-
crisitem.project.funder
European Commission
-
crisitem.project.funder
European Commission
-
crisitem.project.funder
European Commission
-
crisitem.project.grantno
101099963
-
crisitem.project.grantno
101117736
-
crisitem.project.grantno
101042881
-
Appears in Collections: